Literature DB >> 11561090

Bidirectional changes in ethanol consumption in rats with site-specific antisense down-regulation of 5-hydroxytryptamine2A receptors in brain.

G G Blakley1, L A Pohorecky, D Benjamin.   

Abstract

The 5-hydroxytryptamine (5-HT)2A receptor is an important component of the neural substrates underlying ethanol (EtOH) intake and behaviors related to anxiety and stress. Paradoxically, both 5-HT2A agonists and antagonists have been shown to reduce EtOH intake, however the mechanisms underlying these effects are not understood. This inconsistency could possibly be explained by their chronic down-regulation of the 5-HT2A receptor. To further address these findings, the present study sought to functionally characterize the role of localized 5-HT2A receptors in regulating EtOH ingestion by producing central nervous system site-specific receptor down-regulation through infusion of antisense oligonucleotide (ASO). Rats were infused with 5-HT2A receptor ASO into the lateral ventricle (i.c.v.), prefrontal cortex (PFC), central amygdaloid nucleus, medial and lateral division (CeA/L), dorsal raphe nucleus (DRN), or hippocampus (HIP) for a period of 26 days. Subjects were tested for EtOH intake and behaviors related to anxiety and stress. ASO administration i.c.v. and into the CeA/L significantly reduced EtOH intake. PFC 5-HT2A ASO administration increased EtOH intake. Administration of 5-HT2A ASO into the DRN and HIP had no effect on EtOH intake. Intracerebroventricular ASO administration increased activity in a novel open field and increased anxiety-like behavior in the elevated plus maze. PFC ASO administration produced an anxiogenic effect in the elevated plus maze. Intracerbroventricular, PFC, and CeA/L ASO infusions altered adrenocortical function. These differential behavioral effects specific to the anatomical locations targeted for 5-HT2A receptor down-regulation may help resolve a long-standing, apparent inconsistency in the role of 5-HT2A receptors in EtOH consumption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561090

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Neurotensin in the posterior thalamic paraventricular nucleus: inhibitor of pharmacologically relevant ethanol drinking.

Authors:  Surya Pandey; Preeti S Badve; Genevieve R Curtis; Sarah F Leibowitz; Jessica R Barson
Journal:  Addict Biol       Date:  2017-09-06       Impact factor: 4.280

Review 2.  Driving the Downward Spiral: Alcohol-Induced Dysregulation of Extended Amygdala Circuits and Negative Affect.

Authors:  Samuel W Centanni; Gaurav Bedse; Sachin Patel; Danny G Winder
Journal:  Alcohol Clin Exp Res       Date:  2019-08-30       Impact factor: 3.455

3.  Regulation of 5-HT2A/C receptors and DOI-induced behaviors by protein kinase Cgamma.

Authors:  Barbara J Bowers; Jill Miyamoto-Ditmon; Jeanne M Wehner
Journal:  Pharmacol Biochem Behav       Date:  2006-11-15       Impact factor: 3.533

4.  Behavioral and endocrine changes following antisense oligonucleotide-induced reduction in the rat NOP receptor.

Authors:  Gregory G Blakley; Larissa A Pohorecky; Daniel Benjamin
Journal:  Psychopharmacology (Berl)       Date:  2003-11-18       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.